SCHEMBL2295962

SCHEMBL2295962

COC[C@@H](OCC(=O)O)[C@]1(C(C)C)CCC[C@@H](C)C1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426509 0.74 CYP1A2 (0.36) CYP1A2
SCHEMBL5420890 0.73 CYP1A2 (0.39) CYP1A2
SCHEMBL5420894 0.73 CYP1A2 (0.39) CYP1A2
SCHEMBL80851 0.73 CYP1A2 (0.39) CYP1A2
SCHEMBL5435204 0.72 CYP1A2 (0.41) CYP1A2
SCHEMBL7702698 0.72 CYP1A2 (0.41) CYP1A2
SCHEMBL5326914 0.71 CYP1A2 (0.37) CYP1A2
SCHEMBL1897801 0.71 CYP1A2 (0.37) CYP1A2
SCHEMBL3722471 0.70 CYP1A2 (0.47) CYP1A2
SCHEMBL1897803 0.69 CYP1A2 (0.38) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240058259-A1 COMPOSITIONS COMPRISING ESSENTIAL OILS FIRMENICH SA (CH) 2024-02-22 US claimed
US-20240000746-A1 New Cooling Agents and Preparations Containing Them SYMRISE AG (DE) 2024-01-04 US claimed
EP-4247791-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2023-09-27 EP claimed
WO-2023144326-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-08-03 WO claimed
WO-2023117119-A1 ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-06-29 WO claimed
EP-3996505-A1 SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS Bedoukian Research, Inc. (US) 2022-05-18 EP claimed
EP-3996506-A1 FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS Bedoukian Research, Inc. (US) 2022-05-18 EP claimed
WO-2021071896-A1 SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS BEDOUKIAN RESEARCH, INC. (US) 2021-04-15 WO claimed
WO-2021071898-A1 FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS BEDOUKIAN RESEARCH, INC. (US) 2021-04-15 WO claimed
US-20210100242-A1 FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS BEDOUKIAN RESEARCH, INC. (US) 2021-04-08 US claimed
EP-2785309-A1 COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT Henkel AG & Co. KGaA (DE) 2014-10-08 EP claimed
US-20140271518-A1 COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT HENKEL AG & CO. KGAA (DE) 2014-09-18 US claimed
EP-2758029-A1 WATER-FREE FORMULATIONS HAVING A COOLING EFFECT Henkel AG&Co. KGAA (DE) 2014-07-30 EP claimed
WO-2013079349-A1 COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT HENKEL AG & CO. KGAA (DE) 2013-06-06 WO claimed
WO-2013041611-A1 WATER-FREE FORMULATIONS HAVING A COOLING EFFECT HENKEL AG & CO. KGAA (DE) 2013-03-28 WO claimed
US-20110195042-A1 Compositions, Methods and Kits Useful for Treating a Respiratory Symptom THE PROCTER & GAMBLE COMPANY 2011-08-11 US claimed
US-20070233026-A1 Absorbent articles with feedback signal upon urination THE PROCTER & GAMBLE COMPANY 2007-10-04 US claimed
EP-1034161-B2 NOVEL COMPOUNDS DERIVED FROM MENTHOL AND USE AS REFRESHING AGENT FIRMENICH & CIE (CH) 2006-03-15 EP claimed
EP-1034161-B1 NOVEL COMPOUNDS DERIVED FROM MENTHOL AND USE AS REFRESHING AGENT FIRMENICH & CIE (CH) 2002-09-18 EP claimed
US-6359168-B1 ORGANOLEPTIC FIRMENICH SA (CH) 2002-03-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210100242-A1 FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS ACHE, NISCH, DDT CYP1A2 1272/4885
US-20110195042-A1 Compositions, Methods and Kits Useful for Treating a Respiratory Symptom MUC1, TAS2R42, TAS2R7 CYP1A2 3308/4885
US-20240000746-A1 New Cooling Agents and Preparations Containing Them TTPA, TREH, TAS2R45 CYP1A2 2169/4885
US-20140271518-A1 COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT ALOX5, CUTA, OR51E2 CYP1A2 3473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.